Arkolith/Insider Trading/FDMT/Form 4

Kirn David

Chief Executive Officer, Director4D Molecular Therapeutics, Inc. (FDMT) · full profile →Form 4 · filed Jul 12, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$291K
Net Open-Market Flow
-$291K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 10, 2024Option exercise(M)12K$14.42$168K1.1M
Jul 10, 2024Option exercise(M)1K$15.78$20K1.1M
Jul 10, 2024Sell(S)13K$22.49$291K1.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 10, 2024Option exercise(M)1K—$0149K
Jul 10, 2024Option exercise(M)12K—$0565K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-083303) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML